A previous study identified Rgs4 as a novel target of mTOR inhibition in a mouse glioma model31 and since the PI3K/Akt that mediates Rgs4 activity is one of the major drivers of mTOR activity, we wondered whether Rgs4 is required for mTOR activation in vivo. Here, MTOR is linked to central nervous system cancer.